Опубликована: Окт. 25, 2024
Язык: Английский
Опубликована: Окт. 25, 2024
Язык: Английский
Handbook of experimental pharmacology, Год журнала: 2024, Номер unknown
Опубликована: Янв. 1, 2024
Язык: Английский
Процитировано
0Expert Opinion on Investigational Drugs, Год журнала: 2024, Номер 33(2), С. 105 - 114
Опубликована: Янв. 31, 2024
Sjögren's syndrome is a heterogeneous autoimmune condition that impairs quality of life because dryness, fatigue, pain, and systemic involvements. Current treatment largely depends on empirical evidence, with no effective therapy approved. Clinical trials targeted drugs often fail to report efficacy due common factors.
Язык: Английский
Процитировано
0médecine/sciences, Год журнала: 2024, Номер 40(5), С. 414 - 416
Опубликована: Май 1, 2024
Процитировано
0Drug Development Research, Год журнала: 2024, Номер 85(6)
Опубликована: Сен. 1, 2024
Abstract In 2023, the U.S. Food and Drug Administration has approved 29 small molecule drugs. These newly drugs possess distinct scaffolds, thereby exhibiting diverse mechanisms of action binding modalities. Moreover, marketed have always been an important source new drug development creative inspiration, fostering analogous endeavors in discovery that potentially extend to clinical indications. Therefore, conducting a comprehensive evaluation approval experience associated information will facilitate expedited identification highly potent molecules. this review, we comprehensively summarized relevant regarding applications, chemical synthesis drugs, with aim providing promising structural basis design inspiration for pharmaceutical chemists.
Язык: Английский
Процитировано
0Опубликована: Окт. 25, 2024
Язык: Английский
Процитировано
0